We are live on
!
Find out more
VCG
Vantage Consulting Group Portfolio holdings
AUM
$19.7M
1-Year Est. Return
280.87%
This Fund
S&P 500
This Quarter
Est. Return
+17.65%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
–
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
86.51%
Top 10 Holdings %
Top 10 Hldgs %
94.5%
Holding
1,884
New
1,883
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$911M |
| 2 |
ADC Therapeutics
ADCT
|
+$55.1M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$25.5M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$5.96M |
| 5 |
Kroger
KR
|
+$366K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.04% |
| 2 | Technology | 0.89% |
| 3 | Consumer Discretionary | 0.79% |
| 4 | Industrials | 0.61% |
| 5 | Consumer Staples | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Old Republic International
ORI
$10.5B
| $8K | ﹤0.01% |
+412
| New | +$7.24K |
|
1327
Oshkosh
OSK
$8.79B
| $8K | ﹤0.01% |
+88
| New | +$7K |
|
1328
Patterson-UTI
PTEN
$3.98B
| $8K | ﹤0.01% |
+1,572
| New | +$6.18K |
|
1329
Rogers Corp
ROG
$2.21B
| $8K | ﹤0.01% |
+51
| New | +$6.75K |
|
1330
SAP
SAP
$212B
| $8K | ﹤0.01% |
+63
| New | +$8.13K |
|
1331
SolarEdge
SEDG
$2.51B
| $8K | ﹤0.01% |
+25
| New | +$6.91K |
|
1332
SLM Corp
SLM
$4.89B
| $8K | ﹤0.01% |
+656
| New | +$6.9K |
|
|
TBI
1333
Trueblue
TBI
$215M
| $8K | ﹤0.01% |
+406
| New | +$7.3K |
|
1334
Texas Capital Bancshares
TCBI
$4.3B
| $8K | ﹤0.01% |
+137
| New | +$6.77K |
|
1335
Hanover Insurance
THG
$8.1B
| $8K | ﹤0.01% |
+67
| New | +$7.23K |
|
1336
Trinity Industries
TRN
$2.49B
| $8K | ﹤0.01% |
+292
| New | +$6.58K |
|
1337
TTEC Holdings
TTEC
$121M
| $8K | ﹤0.01% |
+112
| New | +$7.27K |
|
1338
UNIFI
UFI
$119M
| $8K | ﹤0.01% |
+435
| New | +$6.73K |
|
1339
Bristow Group
VTOL
$1.34B
| $8K | ﹤0.01% |
+302
| New | +$7.37K |
|
1340
WaFd
WAFD
$2.72B
| $8K | ﹤0.01% |
+311
| New | +$7.4K |
|
1341
Williams-Sonoma
WSM
$26.9B
| $8K | ﹤0.01% |
+150
| New | +$7.68K |
|
1342
XPO
XPO
$23.5B
| $8K | ﹤0.01% |
+205
| New | +$7.43K |
|
|
TXNM
1343
TXNM Energy Inc
TXNM
$6.41B
| $8K | ﹤0.01% |
+171
| New | +$8.25K |
|
|
INVX
1344
Innovex International
INVX
$1.96B
| $8K | ﹤0.01% |
+269
| New | +$7.64K |
|
|
LTHM
1345
DELISTED
Livent Corporation
LTHM
| $8K | ﹤0.01% |
+402
| New | +$5.61K |
|
|
FOE
1346
DELISTED
Ferro Corporation
FOE
| $8K | ﹤0.01% |
+525
| New | +$7.29K |
|
|
XEC
1347
DELISTED
CIMAREX ENERGY CO
XEC
| $8K | ﹤0.01% |
+213
| New | +$6.82K |
|
|
SYKE
1348
DELISTED
SYKES Enterprises Inc
SYKE
| $8K | ﹤0.01% |
+210
| New | +$7.84K |
|
|
EFOR
1349
Everforth Inc
EFOR
$1.17B
| $7K | ﹤0.01% |
+81
| New | +$6.23K |
|
1350
AdvanSix
ASIX
$541M
| $7K | ﹤0.01% |
+372
| New | +$6.38K |
|
Similar funds
MVG
NCM
FFGIM
PIM
HFG
SWM
ICM
SM
Vantage Consulting Group's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Vantage Consulting Group, which disclosed 1,884 positions worth $1.23B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is Royalty Pharma: 21,477,282 shares worth $1.07B.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Technology and Consumer Discretionary.
- Vantage Consulting Group's largest Q4 2020 buy was Royalty Pharma: 21,477,282 shares worth $1.07B.
- Vantage Consulting Group's ten largest holdings make up 94% of its $1.23B portfolio in Q4 2020.
- Vantage Consulting Group disclosed 1,884 positions in Q4 2020, its first 13F filing on record.
Based on Vantage Consulting Group's 13F filing for Q4 2020, filed 12 Feb 2021.